Mesoblast (MESO) Change in Cash (2016 - 2023)
Mesoblast (MESO) reported Change in Cash of $22.5 million for Q2 2023, up 239.23% on a YoY basis from $6.6 million in Q2 2022, and up 219.88% sequentially from -$18.8 million in Q1 2023.
Mesoblast (MESO) Change in Cash (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has 8 years of Change in Cash data on file, last reported at $22.5 million in Q2 2023.
- For the quarter ending Q2 2023, Change in Cash rose 239.23% year-over-year to $22.5 million; the trailing twelve-month figure through Jun 2023 stood at $11.0 million (up 114.55% YoY), and the FY2025 full-year result was $97.5 million, up 1274.3% from the prior year.
- Change in Cash grew to $22.5 million in Q2 2023, from -$18.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $81.0 million in Q1 2021 to a low of -$31.7 million in Q4 2020.
- A 5-year average of -$439500.0 and a median of -$18.3 million in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash slumped 208.58% in 2020 and jumped 491.98% in 2021, its largest moves.
- Tracing MESO's Change in Cash over 5 years: stood at $46.4 million in 2019, then slumped by 168.33% to -$31.7 million in 2020, then jumped by 33.25% to -$21.2 million in 2021, then climbed by 12.66% to -$18.5 million in 2022, then soared by 221.59% to $22.5 million in 2023.
- Business Quant data shows MESO's Change in Cash at $22.5 million in Q2 2023, -$18.8 million in Q1 2023, and -$18.5 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 22.50 Mn |
| Mar 31, 2023 | -18.76 Mn |
| Dec 31, 2022 | -18.50 Mn |
| Sep 30, 2022 | 25.81 Mn |
| Jun 30, 2022 | -16.16 Mn |
| Mar 31, 2022 | -18.10 Mn |
| Dec 31, 2021 | -21.18 Mn |
| Sep 30, 2021 | -20.45 Mn |
| Jun 30, 2021 | -21.38 Mn |
| Mar 31, 2021 | 80.96 Mn |
| Dec 31, 2020 | -31.73 Mn |
| Sep 30, 2020 | -21.71 Mn |
| Jun 30, 2020 | 67.47 Mn |
| Mar 31, 2020 | -20.65 Mn |
| Dec 31, 2019 | 46.44 Mn |
| Sep 30, 2019 | -15.85 Mn |
| Jun 30, 2019 | -19.92 Mn |
| Mar 31, 2019 | -6.69 Mn |
| Dec 31, 2018 | 21.91 Mn |
| Sep 30, 2018 | 17.52 Mn |